ArticleJournal of neurology2026
Comparing phenotypic features between Parkinson's disease dementia and dementia with Lewy bodies.
Article in Journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundParkinson's disease dementia (PDD) and dementia with Lewy bodies (DLB) are two synucleinopathies that share considerable overlap in their clinical and pathological characteristics.
objectiveThis study aimed to evaluate the profile of phenotypic features across PDD and DLB to highlight their shared and distinctive features to explore any possible neurobiological underpinnings.
methodsPatients diagnosed with Parkinson's disease dementia (PDD) (n=31) and dementia with Lewy bodies (DLB) (n=30) underwent evaluation for motor and non-motor symptoms using the International Parkinson and Movement Disorder Society -Unified Parkinson's Disease Rating Scale, the Scales for Outcomes in Parkinson's Disease-Psychiatric Complications, the Montreal Cognitive Assessment, the Hospital Anxiety and Depression Scale and the Epworth Sleepiness Scale.
resultsPatients with PDD showed a more severe phenotype than those with DLB, with higher scores in motor severity, hallucinations, delusions, somnolence, and urinary dysfunction (all p≤0.01). The correlations between neuropsychiatric symptoms differed between groups. In both PDD and DLB, depression correlated with anxiety (PDD ρ=0.54; DLB ρ=0.65; both p<0.001). In PDD, depression was additionally correlated with delusions (ρ=0.47; p<0.001), apathy (ρ=0.41; p<0.001), and sexual preoccupation (ρ=0.35; p<0.001), whereas in DLB depression correlated with hallucinations (ρ=0.38; p<0.001). PDD patients showed greater impairment in activities of daily living (ADLs) than DLB patients (p<0.001), correlating with motor severity (ρ=0.65; p<0.001) and fatigue (ρ=0.58; p<0.001). In DLB, impaired ADLs were linked to hallucinations (ρ=0.39; p<0.05), poorer cognition (ρ=0.47; p<0.01), urinary dysfunction (ρ=0.38; p<0.001), and fatigue (ρ=0.45; p<0.001).
conclusionDespite being grouped under Lewy body dementias, these findings show PDD and DLB have distinct phenotypes reflecting their neurobiological underpinnings. This has implications for symptomatic and disease-modifying management. Future research should explore pathological mechanisms of these characteristics to improve diagnosis and treatment strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.